Naoki Manda
Overview
Explore the profile of Naoki Manda including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
142
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nomoto H, Kito K, Iesaka H, Oe Y, Kawata S, Tsuchida K, et al.
Pharmaceutics
. 2023 Jul;
15(7).
PMID: 37514025
Pemafibrate, a novel selective peroxisome proliferator-activated receptor modulator, has beneficial effects on lipid metabolism. However, its effects on glucose metabolism in individuals with type 2 diabetes (T2DM) remain to be...
2.
Iijima Y, Nakayama M, Miwa T, Yakou F, Tomiyama H, Shikuma J, et al.
Intern Med
. 2023 Mar;
62(5):681-688.
PMID: 36858619
Objective This study analyzed changes in the estimated glomerular filtration rate calculated using cystatin C (eGFRcys) and sodium excretion in the urine after administering dapagliflozin as an add-on therapy to...
3.
Tsuchida K, Taneda S, Yokota I, Okada K, Kurihara Y, Yokoyama H, et al.
J Diabetes Investig
. 2022 Jun;
13(11):1834-1841.
PMID: 35735780
Aims/introduction: Few studies have investigated the renoprotective effect of glucagon-like peptide-1 (GLP-1) receptor in patients with chronic kidney disease (CKD). This study evaluated the effect of dulaglutide 0.75 mg on...
4.
Hamada Y, Hirano E, Sugimoto K, Hanada K, Kaku T, Manda N, et al.
J Med Case Rep
. 2022 Jan;
16(1):26.
PMID: 35065677
Background: Human hepcidin, produced by hepatocytes, regulates intestinal iron absorption, iron recycling by macrophages, and iron release from hepatic storage. Recent studies indicate that hepcidin deficiency is the underlying cause...
5.
Bando H, Taneda S, Manda N
J Nutr Sci Vitaminol (Tokyo)
. 2021 Nov;
67(5):266-272.
PMID: 34719611
Low 25 hydroxyvitamin D (25(OH)D) levels are closely associated with the risk of cardiovascular disease. Vitamin D deficiency is more common in patients with type 2 diabetes mellitus than in...
6.
Bando H, Taneda S, Manda N
JMA J
. 2021 May;
4(2):135-140.
PMID: 33997447
Introduction: Pemafibrate is a potent selective peroxisome proliferator-activated receptor α (PPARα) modulator that may be safer than conventional PPARα agonists in the treatment of dyslipidemia. This study was designed to...
7.
Cho K, Nakamura A, Oba-Yamamoto C, Tsuchida K, Yanagiya S, Manda N, et al.
Diabetes Metab J
. 2019 Nov;
44(4):532-541.
PMID: 31769240
Background: To explore the efficacy and safety of switching from once-daily basal insulin therapy to once-daily pre-meal injection insulin degludec/insulin aspart (IDegAsp) with respect to the glycemic control of participants...
8.
Cho K, Nomoto H, Nakamura A, Kawata S, Sugawara H, Takeuchi J, et al.
Diabetes Obes Metab
. 2019 Sep;
22(3):458-462.
PMID: 31486230
This multicentre, prospective, randomized, open-label, blinded-endpoint, parallel-group, short-term (4-5 weeks) controlled trial was conducted to investigate the superiority of the effect of reducing mean amplitude of glycaemic excursions (MAGE) during...
9.
Cho K, Nakamura A, Omori K, Takase T, Miya A, Manda N, et al.
Diabetes Obes Metab
. 2018 Oct;
21(3):710-714.
PMID: 30311367
The effects of dapagliflozin (DAP) and pioglitazone (PIO) on body weight and glycaemic control were compared in patients with type 2 diabetes mellitus. Seventy-one patients on PIO were either switched...
10.
Kikuchi M, Hirokawa N, Hagiwara S, Nakayama H, Taneda S, Manda N, et al.
Ultrasound Med Biol
. 2018 Sep;
44(12):2840.
PMID: 30190150
No abstract available.